Raghava N. Sriramaneni

1.0k total citations
28 papers, 532 citations indexed

About

Raghava N. Sriramaneni is a scholar working on Immunology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Raghava N. Sriramaneni has authored 28 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 15 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Raghava N. Sriramaneni's work include Immunotherapy and Immune Responses (15 papers), Cancer Immunotherapy and Biomarkers (14 papers) and CAR-T cell therapy research (5 papers). Raghava N. Sriramaneni is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), Cancer Immunotherapy and Biomarkers (14 papers) and CAR-T cell therapy research (5 papers). Raghava N. Sriramaneni collaborates with scholars based in United States, Malaysia and India. Raghava N. Sriramaneni's co-authors include Zachary S. Morris, Ravi B. Patel, KyungMann Kim, Peter M. Carlson, Shaoqin Gong, Ian S. Arthur, Xing Wang, Yuyuan Wang, Ryan Brown and Ben Ma and has published in prestigious journals such as Advanced Materials, ACS Nano and Cancer Research.

In The Last Decade

Raghava N. Sriramaneni

28 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raghava N. Sriramaneni United States 13 242 193 170 135 64 28 532
Xiaolu Yu China 15 159 0.7× 192 1.0× 71 0.4× 266 2.0× 126 2.0× 29 643
Zhenghua Zhang China 16 173 0.7× 91 0.5× 66 0.4× 327 2.4× 69 1.1× 63 715
Mohd M. Khan United States 12 197 0.8× 92 0.5× 47 0.3× 322 2.4× 43 0.7× 23 650
Yujue Wang China 15 101 0.4× 140 0.7× 54 0.3× 407 3.0× 61 1.0× 48 686
Yan Lin China 15 132 0.5× 155 0.8× 64 0.4× 522 3.9× 59 0.9× 44 779
U‐Ging Lo United States 18 93 0.4× 168 0.9× 48 0.3× 409 3.0× 192 3.0× 24 770
Fatemeh Karimi Dermani Iran 7 145 0.6× 291 1.5× 41 0.2× 247 1.8× 73 1.1× 8 587
Chenchen Zhao China 11 86 0.4× 72 0.4× 143 0.8× 167 1.2× 42 0.7× 20 404
Manhua Cui China 18 194 0.8× 214 1.1× 32 0.2× 591 4.4× 44 0.7× 55 984

Countries citing papers authored by Raghava N. Sriramaneni

Since Specialization
Citations

This map shows the geographic impact of Raghava N. Sriramaneni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raghava N. Sriramaneni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raghava N. Sriramaneni more than expected).

Fields of papers citing papers by Raghava N. Sriramaneni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raghava N. Sriramaneni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raghava N. Sriramaneni. The network helps show where Raghava N. Sriramaneni may publish in the future.

Co-authorship network of co-authors of Raghava N. Sriramaneni

This figure shows the co-authorship network connecting the top 25 collaborators of Raghava N. Sriramaneni. A scholar is included among the top collaborators of Raghava N. Sriramaneni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raghava N. Sriramaneni. Raghava N. Sriramaneni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ravichandran, Kanchana, Kung Wong Lau, J. Millet, et al.. (2025). Abstract 3127: An mRNA-encoded masked IL-12 improves systemic tolerability while maintaining anti-tumor efficacy in preclinical studies. Cancer Research. 85(8_Supplement_1). 3127–3127. 1 indexed citations
2.
O’Leary, Kathleen A., Amber M. Bates, Won Jong Jin, et al.. (2023). Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy. Breast Cancer Research. 25(1). 68–68. 9 indexed citations
3.
Zhang, Ying, Md. Mahfuzur Rahman, Paul A. Clark, et al.. (2023). In Situ Vaccination Following Intratumoral Injection of IL2 and Poly-l-lysine/Iron Oxide/CpG Nanoparticles to a Radiated Tumor Site. ACS Nano. 17(11). 10236–10251. 22 indexed citations
4.
Hassan, Zurina & Raghava N. Sriramaneni. (2021). Insights of the pathophysiology of neurodegenerative diseases and the role of phytochemical compounds in its management. 4(3). 1–10. 1 indexed citations
5.
Bates, Amber M., Ryan Brown, Alexander Pieper, et al.. (2021). Combination of Bempegaldesleukin and Anti-CTLA-4 Prevents Metastatic Dissemination After Primary Resection or Radiotherapy in a Preclinical Model of Non-Small Cell Lung Cancer. Frontiers in Oncology. 11. 645352–645352. 3 indexed citations
6.
Jagodinsky, Justin C., Paul A. Clark, Raghava N. Sriramaneni, et al.. (2021). A multipurpose brachytherapy catheter to enable intratumoral injection. Brachytherapy. 20(4). 900–910. 2 indexed citations
7.
Clark, Paul A., Raghava N. Sriramaneni, Amber M. Bates, et al.. (2021). Low-Dose Radiation Potentiates the Propagation of Anti-Tumor Immunity against Melanoma Tumor in the Brain after In Situ Vaccination at a Tumor outside the Brain. Radiation Research. 195(6). 522–540. 13 indexed citations
8.
Jin, Won Jong, Amy K. Erbe, Raghava N. Sriramaneni, et al.. (2020). Tumor-Specific Antibody, Cetuximab, Enhances the In Situ Vaccine Effect of Radiation in Immunologically Cold Head and Neck Squamous Cell Carcinoma. Frontiers in Immunology. 11. 591139–591139. 21 indexed citations
9.
Baniel, Claire, Peter M. Carlson, Won Jong Jin, et al.. (2020). In situ Vaccine Plus Checkpoint Blockade Induces Memory Humoral Response. Frontiers in Immunology. 11. 1610–1610. 12 indexed citations
10.
Patel, Ravi B., Mingzhou Ye, Peter M. Carlson, et al.. (2019). Development of an In Situ Cancer Vaccine via Combinational Radiation and Bacterial‐Membrane‐Coated Nanoparticles. Advanced Materials. 31(43). e1902626–e1902626. 189 indexed citations
11.
Morris, Zachary S., Lauryn R. Werner, Peter M. Carlson, et al.. (2018). Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites. Cancer Immunology Research. 6(7). 825–834. 54 indexed citations
12.
Verma, Rohit Kumar, et al.. (2018). Current updates on pharmacological roles of glucagon-like peptide 1 in obesity. Panminerva Medica. 60(4). 224–225. 4 indexed citations
13.
Patel, Ravi B., Claire Baniel, Raghava N. Sriramaneni, et al.. (2018). Combining brachytherapy and immunotherapy to achieve in situ tumor vaccination: A review of cooperative mechanisms and clinical opportunities. Brachytherapy. 17(6). 995–1003. 30 indexed citations
14.
Patel, Ravi B., Reinier Hernandez, Ryan Brown, et al.. (2018). Systemic Administration of Molecularly Targeted Radiation Therapy (MTRT) Improves the Efficacy of anti-CTLA-4 in a Murine B78 Melanoma Model. International Journal of Radiation Oncology*Biology*Physics. 102(3). S154–S154. 1 indexed citations
15.
Werner, Lauryn R., Jasdeep S. Kler, Joseph G. Kern, et al.. (2017). Transcriptional-mediated effects of radiation on the expression of immune susceptibility markers in melanoma. Radiotherapy and Oncology. 124(3). 418–426. 20 indexed citations
16.
Yalavarthi, Prasanna Raju, et al.. (2014). In-Vitro Assessment and Pharmacodynamics of Nimesulide Incorporated Aloe vera Transemulgel. Current Drug Discovery Technologies. 11(2). 162–167. 15 indexed citations
17.
Salman, Ibrahim M., Munavvar Abdul Sattar, Nor A. Abdullah, et al.. (2009). The Role of Renal Sympathetic Nerve Activity in Mediating Renal Hemodynamic Alterations in Rat Models of Renal Impairment. Advances in Clinical and Experimental Medicine. 18(3). 205–214. 3 indexed citations
18.
Ameer, Omar Z., Ibrahim M. Salman, Jamshed Siddiqui, et al.. (2009). In Vitro Cholinomimetic Effect of Loranthus Ferrugineus in Isolated Guinea Pig Ileum. Journal of Acupuncture and Meridian Studies. 2(4). 288–293. 6 indexed citations
19.
Ameer, Omar Z., Ibrahim M. Salman, Jamshed Siddiqui, et al.. (2009). Characterization of the Possible Mechanisms Underlying the Hypotensive and Spasmogenic Effects ofLoranthus ferrugineusMethanolic Extract. The American Journal of Chinese Medicine. 37(5). 991–1008. 12 indexed citations
20.
Ameer, Omar Z., Ibrahim M. Salman, Jamshed Siddiqui, et al.. (2009). Pharmacological mechanisms underlying the vascular activities of Loranthus ferrugineus Roxb. in rat thoracic aorta. Journal of Ethnopharmacology. 127(1). 19–25. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026